Anitrazafen

CAS: 63119-27-7

Ref. 3D-NCA11927

Produktinformation

• Name: Anitrazafen
• Synonyme: 1,2,4-Triazine, 5,6-bis(4-methoxyphenyl)-3-methyl-, 5,6-Bis(4-Methoxyphenyl)-3-Methyl-1,2,4-Triazine, 5,6-Bis(p-methoxyphenyl)-3-methyl-1,2,4-triazine, 5,6-Bis(p-methoxyphenyl)-3-methyl-as-triazine, Anitrazafen [USAN:INN], Anitrazafene, Anitrazafene [INN-French], Anitrazafeno, Anitrazafeno [INN-Spanish], Anitrazafenum, Anitrazafenum [INN-Latin], Ly 122512, NSC 336394, Unii-2Y065P7Myr

Beschreibung

Antrazafen is an antibacterial drug that belongs to the class of fatty acids. It is used as a diagnostic agent to identify damaged cardiac tissue, and has been shown to have biological properties that can be used in autoimmune diseases. Antrazafen inhibits the production of inflammatory bowel disease by preventing activation of effector proteins, which are proteins that are involved in the immune response. This drug also prevents chronic arthritis by inhibiting glycosidic bonds. The biocompatible polymer coating on antrazafen makes it suitable for use in humans with damaged tissue or joints.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 307.3 g/mol
• Formel: C₁₈H₁₇N₃O₂
• Reinheit: Min. 95%